- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
已有166家主力机构披露2025-06-30报告期持股数据，持仓量总计5.20亿股，占流通A股43.37%
- 波段诊断：
-
技术面诊股
诊断结果：5.6技术面打败了43%的股票
技术面评分前10的股票
近期的平均成本为10.37元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为10.37元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"10.37","date":1760345827,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，跑赢行业平均水平。
[{"date":"2025.10.14","stock":"-1.25","trade":"-1.22","ind":"-0.62"},{"date":"2025.10.13","stock":"-1.89","trade":"-0.84","ind":"-0.19"},{"date":"2025.10.10","stock":"0.76","trade":"-0.24","ind":"-0.94"},{"date":"2025.10.09","stock":"1.15","trade":"-0.39","ind":"1.32"},{"date":"2025.09.30","stock":"0.10","trade":"0.72","ind":"0.52"},{"date":"2025.09.29","stock":"1.27","trade":"-0.14","ind":"0.90"},{"date":"2025.09.26","stock":"-0.68","trade":"-1.67","ind":"-0.65"},{"date":"2025.09.25","stock":"-0.67","trade":"-0.91","ind":"-0.01"},{"date":"2025.09.24","stock":"1.46","trade":"1.94","ind":"0.83"},{"date":"2025.09.23","stock":"-2.29","trade":"-1.95","ind":"-0.18"},{"date":"2025.09.22","stock":"-0.38","trade":"-0.40","ind":"0.22"},{"date":"2025.09.19","stock":"-1.96","trade":"-1.50","ind":"-0.30"},{"date":"2025.09.18","stock":"1.03","trade":"-0.61","ind":"-1.15"},{"date":"2025.09.17","stock":"1.72","trade":"-0.67","ind":"0.37"},{"date":"2025.09.16","stock":"-1.14","trade":"-0.09","ind":"0.04"},{"date":"2025.09.15","stock":"-0.66","trade":"-0.14","ind":"-0.26"},{"date":"2025.09.12","stock":"0.47","trade":"0.60","ind":"-0.12"},{"date":"2025.09.11","stock":"0.95","trade":"0.29","ind":"1.65"},{"date":"2025.09.10","stock":"0.29","trade":"-0.63","ind":"0.13"},{"date":"2025.09.09","stock":"-2.06","trade":"-1.92","ind":"-0.51"},{"date":"2025.09.08","stock":"0.47","trade":"0.35","ind":"0.38"}]
海正药业,上证指数,化学制药指数
压力支撑
该股压力位为10.32元，支撑位为10.17元。
[{"text":"\u538b\u529b\u4f4d","value":"10.32","date":1760371200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"10.17","date":1760371200,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.9资金面打败了18%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：10月14日 20:37
| 机构今日流向(万元) | -3771.47 | 机构5日流向(万元) | -7029.63 |
| 机构10日流向(万元) | -12231.12 | 机构20日流向(万元) | -29710.09 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加1008.53万股，其中基金净增仓10家，主力净增仓64家，有一定的中长期投资价值。
截止2025-06-30，共166家主力机构（基金162家，一般法人4家），持仓量总计51960.88万股，占流通A股43.37%
其中，基金持仓与2024-12-31相比：
增仓：29家 ，增持 578.22万股
减仓：19家 ，减持 271.02万股
新出现在主力名单中：110家 ，持有1405.25万股
从主力名单中消失：46家 ，原持有1604.77万股
其中，基金持仓与2024-12-31相比：
增仓：29家 ，增持 578.22万股
减仓：19家 ，减持 271.02万股
新出现在主力名单中：110家 ，持有1405.25万股
从主力名单中消失：46家 ，原持有1604.77万股
消息面诊股
诊断结果：5.5消息面打败了52%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 海正药业：10月13日获融资买入2002.88万元
2025-10-14 - 海正药业：10月10日获融资买入2166.28万元
2025-10-11 - 海正药业：1,4-丁二磺酸腺苷蛋氨酸产品原料在海正
2025-10-10 - 海正药业：特治星二期扩产项目预计明年上半年商业化生
2025-10-10 - 海正药业：公司依维莫司片5mg品规已按新4类获得国
2025-10-10 - 海正药业：后续将根据回购方案及市场情况择机实施回购
2025-10-10 - 海正药业：10月9日获融资买入2744.53万元
2025-10-10 - 海正药业：公司产品通过美国Self-GRAS认证
2025-10-09 - 海正药业：9月30日获融资买入953.11万元
2025-10-01 - 国内首部《医药化工CDMO车间建设标准》10月1日
2025-09-30
消息列表
| 一般消息 | 高管变动 | 取消监事会 | 2025-09-10 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-26 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-26 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-08-26 |
| 利好 | 分红转增 | 10派2.1元(含税) | 2025-03-29 |
| 一般消息 | 重大事项 | 关联交易 | 2025-03-29 |
| 利好 | 业绩预告 | 预计扭亏 | 2025-01-23 |
| 一般消息 | 高管变动 | 委员会更名 | 2024-12-27 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：5.1行业面打败了68%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，明显跑输大盘。
[{"date":"2025.10.14","price":"-0.62","value":"-1.22"},{"date":"2025.10.13","price":"-0.19","value":"-0.84"},{"date":"2025.10.10","price":"-0.94","value":"-0.24"},{"date":"2025.10.09","price":"1.32","value":"-0.39"},{"date":"2025.09.30","price":"0.52","value":"0.72"},{"date":"2025.09.29","price":"0.90","value":"-0.14"},{"date":"2025.09.26","price":"-0.65","value":"-1.67"},{"date":"2025.09.25","price":"-0.01","value":"-0.91"},{"date":"2025.09.24","price":"0.83","value":"1.94"},{"date":"2025.09.23","price":"-0.18","value":"-1.95"},{"date":"2025.09.22","price":"0.22","value":"-0.40"},{"date":"2025.09.19","price":"-0.30","value":"-1.50"},{"date":"2025.09.18","price":"-1.15","value":"-0.61"},{"date":"2025.09.17","price":"0.37","value":"-0.67"},{"date":"2025.09.16","price":"0.04","value":"-0.09"},{"date":"2025.09.15","price":"-0.26","value":"-0.14"},{"date":"2025.09.12","price":"-0.12","value":"0.60"},{"date":"2025.09.11","price":"1.65","value":"0.29"},{"date":"2025.09.10","price":"0.13","value":"-0.63"},{"date":"2025.09.09","price":"-0.51","value":"-1.92"},{"date":"2025.09.08","price":"0.38","value":"0.35"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 向日葵 | 74.68% | -9.87% | 5.0分 |
| 2 | 康芝药业 | 6.75% | 1.28% | 5.8分 |
| 3 | 宏源药业 | 6.01% | 13.80% | 5.0分 |
| 4 | 通化金马 | 2.88% | -1.26% | 5.1分 |
| 5 | 多瑞医药 | 2.16% | 0.96% | 5.5分 |
| 6 | 河化股份 | 2.10% | 0.41% | 6.2分 |
| 8 | ST天圣 | 1.45% | -1.81% | 4.7分 |
| 10 | 鲁抗医药 | 0.20% | 2.16% | 6.0分 |
| 12 | 纳微科技 | -0.80% | -4.43% | 6.1分 |
| 14 | *ST苏吴 | -1.00% | -1.00% | 4.9分 |
| 16 | 仟源医药 | -2.12% | 2.21% | 5.9分 |
| 18 | 天新药业 | -2.75% | 0.26% | 5.6分 |
| 20 | 海欣股份 | -3.08% | -0.90% | 5.7分 |
| 22 | 哈药股份 | -3.22% | 0.28% | 5.6分 |
| 24 | 新和成 | -3.69% | 0.13% | 6.2分 |
| 26 | 德展健康 | -3.78% | -4.01% | 4.7分 |
| 28 | 中关村 | -3.87% | -1.69% | 5.9分 |
| 30 | 海森药业 | -4.17% | 3.12% | 5.3分 |
| 32 | 华特达因 | -4.30% | 2.80% | 5.3分 |
| 34 | 恩华药业 | -4.38% | -7.27% | 4.8分 |
| 36 | 亚太药业 | -4.59% | 5.23% | 5.8分 |
| 38 | 东北制药 | -4.70% | 2.82% | 5.9分 |
| 40 | 富士莱 | -4.92% | -0.53% | 5.6分 |
| 42 | 奥锐特 | -5.12% | -0.09% | 5.9分 |
| 44 | 华邦健康 | -5.23% | 0.00% | 5.9分 |
| 46 | 共同药业 | -5.37% | -0.83% | 5.4分 |
| 48 | 福元医药 | -5.39% | -1.79% | 5.7分 |
| 50 | 丰原药业 | -5.68% | 0.00% | 5.5分 |
| 52 | 新天地 | -5.87% | 3.38% | 5.6分 |
| 54 | 海翔药业 | -6.15% | -1.05% | 4.7分 |
| 56 | 金石亚药 | -6.23% | 1.58% | 5.5分 |
| 58 | 易明医药 | -6.45% | -5.64% | 4.6分 |
| 60 | 莱美药业 | -6.70% | 0.23% | 5.6分 |
| 62 | *ST赛隆 | -6.78% | -6.85% | 5.0分 |
| 64 | 西点药业 | -6.93% | 0.30% | 5.6分 |
| 66 | *ST三圣 | -6.95% | -2.57% | 4.0分 |
| 68 | 宣泰医药 | -7.33% | -3.72% | 5.3分 |
| 70 | 九典制药 | -7.42% | 2.12% | 5.2分 |
| 72 | 赛分科技 | -7.48% | -3.72% | 5.1分 |
| 74 | - | -7.65% | 1.12% | 分 |
| 76 | 润都股份 | -8.05% | 3.82% | 5.5分 |
| 78 | 人福医药 | -8.63% | 0.19% | 5.4分 |
| 80 | 信立泰 | -8.79% | -10.18% | 6.3分 |
| 82 | 复旦张江 | -9.16% | -0.66% | 5.2分 |
| 84 | 华东医药 | -9.42% | -3.96% | 5.7分 |
| 86 | 海南海药 | -9.45% | 0.74% | 5.4分 |
| 88 | 兴齐眼药 | -9.55% | 1.16% | 5.4分 |
| 90 | 亨迪药业 | -9.68% | -1.09% | 5.3分 |
| 92 | 广生堂 | -9.85% | 5.15% | 4.8分 |
| 94 | 司太立 | -10.17% | -0.46% | 5.5分 |
| 96 | 前沿生物 | -10.98% | -5.42% | 4.6分 |
| 98 | 恒瑞医药 | -11.12% | -7.12% | 5.8分 |
| 100 | - | -11.40% | 0.18% | 分 |
| 102 | 灵康药业 | -11.43% | -3.83% | 5.2分 |
| 104 | - | -11.70% | 2.87% | 分 |
| 106 | 仙琚制药 | -11.76% | -2.12% | 5.3分 |
| 108 | 立方制药 | -11.78% | -0.65% | 6.0分 |
| 110 | - | -11.97% | 0.62% | 分 |
| 112 | 复星医药 | -12.22% | -4.09% | 4.9分 |
| 114 | 辰欣药业 | -12.60% | -1.24% | 5.2分 |
| 116 | - | -12.97% | -0.58% | 分 |
| 118 | 吉贝尔 | -13.04% | -8.45% | 5.3分 |
| 120 | 千红制药 | -13.33% | -2.88% | 4.7分 |
| 122 | - | -13.47% | -0.14% | 分 |
| 124 | 百济神州 | -13.93% | -9.07% | 4.7分 |
| 126 | - | -13.96% | -0.76% | 分 |
| 128 | 天宇股份 | -14.30% | -6.74% | 4.6分 |
| 130 | 科伦药业 | -14.98% | -6.44% | 4.8分 |
| 132 | 奥赛康 | -15.12% | -6.15% | 5.6分 |
| 134 | 海思科 | -15.51% | -8.30% | 5.7分 |
| 136 | 泰恩康 | -15.68% | -4.97% | 4.5分 |
| 138 | 美诺华 | -15.75% | 0.28% | 4.6分 |
| 140 | 键凯科技 | -16.10% | -8.29% | 4.9分 |
| 142 | 舒泰神 | -17.00% | -4.22% | 5.3分 |
| 144 | 亚虹医药 | -18.10% | -6.33% | 4.7分 |
| 146 | 微芯生物 | -19.13% | -4.11% | 5.2分 |
| 148 | 一品红 | -20.21% | -6.99% | 4.8分 |
| 150 | 新诺威 | -25.60% | -9.08% | 4.9分 |
| 152 | 海辰药业 | -26.89% | 1.55% | 4.9分 |
| 154 | 华海药业 | -28.80% | -9.08% | 4.8分 |
| 156 | 南新制药 | -42.73% | -31.82% | 4.6分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 61/218 ， 87/218。
[{"date":"2025-06-30","value":"3.58","vol":"1.40"},{"date":"2025-03-31","value":"2.30","vol":"-0.17"},{"date":"2024-12-31","value":"7.31","vol":"19.77"},{"date":"2024-09-30","value":"6.30","vol":"4.61"},{"date":"2024-06-30","value":"5.37","vol":"3.55"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
3.58 | 2.30 | 7.31 | 6.30 | 5.37 |
| 行业(%) | 1.40 | -0.17 | 19.77 | 4.61 | 3.55 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"43.94","vol":"49.76"},{"date":"2025-03-31","value":"42.13","vol":"49.23"},{"date":"2024-12-31","value":"42.46","vol":"51.11"},{"date":"2024-09-30","value":"41.17","vol":"50.51"},{"date":"2024-06-30","value":"39.37","vol":"50.85"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
43.94 | 42.13 | 42.46 | 41.17 | 39.37 |
| 行业(%) | 49.76 | 49.23 | 51.11 | 50.51 | 50.85 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 58/218 ， 105/218。
[{"date":"2025-06-30","value":"0.13","vol":"79.06"},{"date":"2025-03-31","value":"-3.48","vol":"-0.84"},{"date":"2024-12-31","value":"2.86","vol":"17.88"},{"date":"2024-09-30","value":"-9.50","vol":"45.69"},{"date":"2024-06-30","value":"-13.48","vol":"710.38"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
0.13 | -3.48 | 2.86 | -9.50 | -13.48 |
| 行业(%) | 79.06 | -0.84 | 17.88 | 45.69 | 710.38 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"-31.29","vol":"56.66"},{"date":"2025-03-31","value":"-21.85","vol":"-21.21"},{"date":"2024-12-31","value":"745.24","vol":"-21.14"},{"date":"2024-09-30","value":"16.49","vol":"-32.33"},{"date":"2024-06-30","value":"7.70","vol":"8.14"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-31.29 | -21.85 | 745.24 | 16.49 | 7.70 |
| 行业(%) | 56.66 | -21.21 | -21.14 | -32.33 | 8.14 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 20/218 ， 32/218。
[{"date":"2025-06-30","value":"0.33","vol":"0.21"},{"date":"2025-03-31","value":"0.16","vol":"0.10"},{"date":"2024-12-31","value":"0.62","vol":"0.43"},{"date":"2024-09-30","value":"0.47","vol":"0.33"},{"date":"2024-06-30","value":"0.30","vol":"0.23"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.33 | 0.16 | 0.62 | 0.47 | 0.30 |
| 行业(次) | 0.21 | 0.10 | 0.43 | 0.33 | 0.23 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.72","vol":"1.32"},{"date":"2025-03-31","value":"0.86","vol":"0.67"},{"date":"2024-12-31","value":"3.17","vol":"3.24"},{"date":"2024-09-30","value":"2.51","vol":"2.18"},{"date":"2024-06-30","value":"1.71","vol":"1.51"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.72 | 0.86 | 3.17 | 2.51 | 1.71 |
| 行业(次) | 1.32 | 0.67 | 3.24 | 2.18 | 1.51 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 18/218 ， 14/218。
[{"date":"2025-06-30","value":"36.22","vol":"2.81"},{"date":"2025-03-31","value":"9.98","vol":"-28.76"},{"date":"2024-12-31","value":"29.55","vol":"-371.46"},{"date":"2024-09-30","value":"25.62","vol":"-9.87"},{"date":"2024-06-30","value":"18.53","vol":"-253.98"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 36.22 | 9.98 | 29.55 | 25.62 | 18.53 |
| 行业 | 2.81 | -28.76 | -371.46 | -9.87 | -253.98 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.23","vol":"1.73"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.22","vol":"1.99"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.12","vol":"2.19"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.23 | - | 0.22 | - | 0.12 |
| 行业 | 1.73 | 0.00 | 1.99 | 0.00 | 2.19 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 84/218 ， 45/218。
[{"date":"2025-06-30","value":"0.91","vol":"3.66"},{"date":"2025-03-31","value":"0.97","vol":"3.59"},{"date":"2024-12-31","value":"0.92","vol":"3.32"},{"date":"2024-09-30","value":"0.93","vol":"3.66"},{"date":"2024-06-30","value":"0.87","vol":"3.59"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
0.91 | 0.97 | 0.92 | 0.93 | 0.87 |
| 行业 | 3.66 | 3.59 | 3.32 | 3.66 | 3.59 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.61","vol":"2.88"},{"date":"2025-03-31","value":"0.64","vol":"2.81"},{"date":"2024-12-31","value":"0.59","vol":"2.63"},{"date":"2024-09-30","value":"0.61","vol":"2.92"},{"date":"2024-06-30","value":"0.56","vol":"2.88"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.61 | 0.64 | 0.59 | 0.61 | 0.56 |
| 行业 | 2.88 | 2.81 | 2.63 | 2.92 | 2.88 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 22/218 ， 42/218。
[{"date":"2025-06-30","value":"44.81","vol":"33.92"},{"date":"2025-03-31","value":"45.17","vol":"34.04"},{"date":"2024-12-31","value":"46.29","vol":"34.34"},{"date":"2024-09-30","value":"47.74","vol":"33.02"},{"date":"2024-06-30","value":"50.59","vol":"33.19"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
44.81 | 45.17 | 46.29 | 47.74 | 50.59 |
| 行业(%) | 33.92 | 34.04 | 34.34 | 33.02 | 33.19 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.84","vol":"0.89"},{"date":"2025-03-31","value":"0.85","vol":"1.46"},{"date":"2024-12-31","value":"0.89","vol":"0.84"},{"date":"2024-09-30","value":"0.94","vol":"0.73"},{"date":"2024-06-30","value":"1.05","vol":"0.71"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.84 | 0.85 | 0.89 | 0.94 | 1.05 |
| 行业(%) | 0.89 | 1.46 | 0.84 | 0.73 | 0.71 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"4.87","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"4.89","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-0.93","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"6.01","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"7.07","blueLineValue":"0.59","type":"YC"}]